OUE LIPPO HEALTHCARE LTD (5WA) Fair Value & Analysis
Healthcare · SG · Market cap 173M SGD
Fair value as of: Aug 13, 2026
From 14 valuation models · updated 4 days ago
Fair value updated Aug 13, 2026, revised from 0.0898 SGD to 0.0862 SGD (−4.0%) since Aug 9, 2026. Share price +30.0% over the past month.
A solid business, screening 121% undervalued on our models.
What matters now
- The price is below even our cautious bear case (0.0589 SGD). The market is more pessimistic than our downside scenario.
- Solid quality (53/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (0.0589 SGD to 0.1096 SGD) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 0.0190 SGD – 0.0440 SGD · fair‑value band 0.0589 SGD – 0.1096 SGD · the 0.0390 SGD price screens below the 0.0862 SGD fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
OUE LIPPO HEALTHCARE LTD (5WA) currently trades at 0.0390 SGD, while our model-based Fair Value estimate is 0.0862 SGD, implying the stock looks roughly 121.0% undervalued today. The Quality Score stands at 53/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, OUE LIPPO HEALTHCARE LTD generated revenue of 152M SGD at a net margin of -11.1%. Revenue grew 2.5% year over year. It earns a return on equity of 1.2%. Net debt stands at 465M SGD. Fundamentals as of Aug 13, 2026
Our scenario range runs from 0.0589 SGD (bear case) to 0.1096 SGD (bull case); at 0.0390 SGD, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 19% below its 52-week high and 77% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at 121%, 5WA screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Multiples (0.2100 SGD) versus Asset-Based (0.0400 SGD). Highest evidence: Growth DCF (80).
Notify me when 5WA reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 50 · Market factors (momentum, volatility) 75
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
OUE Healthcare Limited, an investment holding company, owns, operates, and invests in healthcare businesses in Singapore, China, Myanmar, Indonesia, and Japan. It operates through Healthcare Operations, Healthcare Assets, Properties Under Development, and Investments segments.
Full company description
OUE Healthcare Limited, an investment holding company, owns, operates, and invests in healthcare businesses in Singapore, China, Myanmar, Indonesia, and Japan. It operates through Healthcare Operations, Healthcare Assets, Properties Under Development, and Investments segments. The company is involved in the operation of hospitals and clinics; supply of medical equipment and pharmaceutical products; and rental of investment properties and owned assets. It also engages in the development of medical facilities, healthcare-related assets, and integrated mixed-used projects; and investment in real estate investment trusts and properties. The company was formerly known as OUE Lippo Healthcare Limited and changed its name to OUE Healthcare Limited in April 2023. The company was founded in 2010 and is headquartered in Singapore. OUE Healthcare Limited is a subsidiary of OUE Limited.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
OUE LIPPO HEALTHCARE LTD reported revenue of 152M SGD in FY2025 versus 19.7M SGD in FY2021, a compound +66.8%/yr. Reported net income was −16.9M SGD in FY2025.
Watch 5WA: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 267 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Tenet Healthcare Corporation THC | $266.79 | $330.25 | +24% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.97 | R$47.31 | +39% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,565 | ₹2,955 | -65% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,008 | ₹284.87 | -72% |
| Bangkok Dusit Medical Services Public Company BDMS | 19.70 THB | 18.57 THB | -6% |
Compare OUE LIPPO HEALTHCARE LTD with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is OUE LIPPO HEALTHCARE LTD (5WA) overvalued or undervalued?
What is the fair value of 5WA?
What is the quality score of 5WA?
What is the revenue of OUE LIPPO HEALTHCARE LTD (5WA)?
What is the net profit margin of 5WA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track OUE LIPPO HEALTHCARE LTD and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.